Building Pharma Brands That Win

Commercial Success in Pharma

In today’s pharma market, commercial success is no longer driven by science alone. It’s the product of clarity of positioning, launch readiness, integrated evidence, and portfolio thinking working together from early development through commercialization.

This Outcomes Rocket series brings together leaders from Lumanity, a global partner to pharma and biotech on strategy, evidence, and commercialization, to unpack what actually moves the needle. Across these conversations, you’ll hear from experts on brand positioning, launch excellence, integrated evidence generation planning, and portfolio strategy as they share the frameworks, decisions, and field-tested lessons behind brands that lead their categories.

Learn more about Lumanity’s commercialization capabilities.

Episode 1

The Positioning Compass: Guiding Pharma Brands from Pipeline to Market

In pharma, the brands that win don’t wait for the market to define them. They define themselves through clear, early, and evolving positioning. In this Outcomes Rocket episode, Lumanity’s Natalie Thovmasian and Liv Yates share why positioning is a strategic driver across the entire pharma lifecycle, how to shape it before clinical data, and how to keep it sharp as markets shift. If you’re building or scaling a pharma brand, this is a must-listen conversation.

Episode 2

From Chaos to Confidence: Mastering Pharma Launch as a First-Time Team

Launching a pharma product is a high-stakes, pressure-filled marathon where poor planning shows up too late to fix. In this episode, Andrew Mooney and Laurence Cooper break down how early planning, focused strategy, and disciplined execution help smaller pharma teams succeed in high-pressure launches. If you’re preparing for a first-time or early-stage pharma launch, this conversation breaks down exactly how to stay focused, avoid costly surprises, and execute with confidence.

Episode 3

Building a Scalable Pharma Launch Engine that Drives Competitive Advantage

Most pharma launch frameworks don’t fail because they lack structure; they fail because they become rigid checklists that suppress strategic thinking. In this episode, Kirsty Tait and Jeff Hart explain that scaling launches requires moving beyond inflexible models toward standardized, yet adaptable systems supported by strong governance, centralized visibility, and execution-focused culture. If your launch process feels slow, inconsistent, or overly complex, this conversation offers a practical blueprint for scaling without losing speed or impact.